SK91594A3 - Trisubstituted pyrimido£5,4-d|-pyrimidines for modulation of multidrugs resistence, medicines containing these compouds and method of their preparation - Google Patents
Trisubstituted pyrimido£5,4-d|-pyrimidines for modulation of multidrugs resistence, medicines containing these compouds and method of their preparation Download PDFInfo
- Publication number
- SK91594A3 SK91594A3 SK915-94A SK91594A SK91594A3 SK 91594 A3 SK91594 A3 SK 91594A3 SK 91594 A SK91594 A SK 91594A SK 91594 A3 SK91594 A3 SK 91594A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- pyrimidine
- methyl
- carbon atoms
- pyrimido
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 24
- 239000003814 drug Substances 0.000 title claims description 8
- 238000000034 method Methods 0.000 title claims description 7
- 229940079593 drug Drugs 0.000 title claims description 3
- -1 cyano, aminocarbonyl Chemical group 0.000 claims description 288
- 125000004432 carbon atom Chemical group C* 0.000 claims description 53
- 125000000217 alkyl group Chemical group 0.000 claims description 51
- 150000001875 compounds Chemical class 0.000 claims description 46
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 39
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 36
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 29
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 27
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 25
- 150000003839 salts Chemical class 0.000 claims description 23
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 18
- 125000003545 alkoxy group Chemical group 0.000 claims description 17
- 229910052801 chlorine Inorganic materials 0.000 claims description 17
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 16
- 239000000460 chlorine Substances 0.000 claims description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims description 15
- 229910052731 fluorine Inorganic materials 0.000 claims description 14
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 13
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 13
- 239000011737 fluorine Substances 0.000 claims description 13
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 13
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 12
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 12
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 11
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 11
- JOZPEVMCAKXSEY-UHFFFAOYSA-N pyrimido[5,4-d]pyrimidine Chemical class N1=CN=CC2=NC=NC=C21 JOZPEVMCAKXSEY-UHFFFAOYSA-N 0.000 claims description 11
- 206010028980 Neoplasm Diseases 0.000 claims description 10
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 10
- 239000002246 antineoplastic agent Substances 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 229940127089 cytotoxic agent Drugs 0.000 claims description 9
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 8
- 125000003282 alkyl amino group Chemical group 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 7
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical group C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 claims description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 125000001624 naphthyl group Chemical group 0.000 claims description 7
- 125000003386 piperidinyl group Chemical group 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 7
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 125000004122 cyclic group Chemical group 0.000 claims description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 6
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 5
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 5
- 125000006239 protecting group Chemical group 0.000 claims description 5
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 4
- 125000001589 carboacyl group Chemical group 0.000 claims description 4
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 230000001235 sensitizing effect Effects 0.000 claims description 4
- NDOVLWQBFFJETK-UHFFFAOYSA-N 1,4-thiazinane 1,1-dioxide Chemical compound O=S1(=O)CCNCC1 NDOVLWQBFFJETK-UHFFFAOYSA-N 0.000 claims description 3
- YHIIJNLSGULWAA-UHFFFAOYSA-N 1,4-thiazinane 1-oxide Chemical compound O=S1CCNCC1 YHIIJNLSGULWAA-UHFFFAOYSA-N 0.000 claims description 3
- YIWSBONCEROBAF-UHFFFAOYSA-N 1-[8-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-2-yl]-n,n-dimethylpiperidin-4-amine Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1C(C1=N2)=NC=NC1=C(N1CCOCC1)N=C2N1CCC(N(C)C)CC1 YIWSBONCEROBAF-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 3
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 claims description 3
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 claims description 3
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 3
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 125000005577 anthracene group Chemical group 0.000 claims description 2
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000001246 bromo group Chemical group Br* 0.000 claims description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
- 150000001728 carbonyl compounds Chemical class 0.000 claims description 2
- 230000000973 chemotherapeutic effect Effects 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 2
- 125000005184 naphthylamino group Chemical group C1(=CC=CC2=CC=CC=C12)N* 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N vinyl-ethylene Natural products C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 claims description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 239000000969 carrier Substances 0.000 claims 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical group CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 1
- JOXIKXRNEMFANG-UHFFFAOYSA-N N1=CN=CC2=C1C=NC=N2.N2=CN=CC=C2 Chemical compound N1=CN=CC2=C1C=NC=N2.N2=CN=CC=C2 JOXIKXRNEMFANG-UHFFFAOYSA-N 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 238000002844 melting Methods 0.000 description 79
- 230000008018 melting Effects 0.000 description 79
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 57
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 54
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 54
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 32
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 30
- 239000005909 Kieselgur Substances 0.000 description 29
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- 239000013543 active substance Substances 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 229960000583 acetic acid Drugs 0.000 description 15
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 14
- 239000012362 glacial acetic acid Substances 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 239000003826 tablet Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 229940009456 adriamycin Drugs 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- CEIXWJHURKEBMQ-UHFFFAOYSA-N Heliamine Chemical compound C1CNCC2=C1C=C(OC)C(OC)=C2 CEIXWJHURKEBMQ-UHFFFAOYSA-N 0.000 description 7
- 235000019359 magnesium stearate Nutrition 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- 238000002512 chemotherapy Methods 0.000 description 6
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 6
- CCMKPVQTRQFFQH-UHFFFAOYSA-N n-benzyl-2-chloro-n-methyl-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCOCC3)N=C(Cl)N=C2C=1N(C)CC1=CC=CC=C1 CCMKPVQTRQFFQH-UHFFFAOYSA-N 0.000 description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 229960004679 doxorubicin Drugs 0.000 description 5
- 239000008298 dragée Substances 0.000 description 5
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- PXSFRIGHWCHZSU-UHFFFAOYSA-N 4-(2,8-dichloropyrimido[5,4-d]pyrimidin-4-yl)morpholine Chemical compound C=12N=CN=C(Cl)C2=NC(Cl)=NC=1N1CCOCC1 PXSFRIGHWCHZSU-UHFFFAOYSA-N 0.000 description 4
- XIVFWOPDLPZENU-UHFFFAOYSA-N 4-pyrimido[5,4-d]pyrimidin-4-ylmorpholine Chemical compound C1COCCN1C1=NC=NC2=CN=CN=C12 XIVFWOPDLPZENU-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000829 suppository Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 2
- QDVBKXJMLILLLB-UHFFFAOYSA-N 1,4'-bipiperidine Chemical compound C1CCCCN1C1CCNCC1 QDVBKXJMLILLLB-UHFFFAOYSA-N 0.000 description 2
- WEBTULVKHZERRR-UHFFFAOYSA-N 1-[8-[benzyl(methyl)amino]-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-2-yl]piperidin-4-one Chemical compound N=1C=NC2=C(N3CCOCC3)N=C(N3CCC(=O)CC3)N=C2C=1N(C)CC1=CC=CC=C1 WEBTULVKHZERRR-UHFFFAOYSA-N 0.000 description 2
- AQHKGPWUIOAPHJ-UHFFFAOYSA-N 2,4,8-trichloropyrimido[5,4-d]pyrimidine Chemical compound N1=CN=C(Cl)C2=NC(Cl)=NC(Cl)=C21 AQHKGPWUIOAPHJ-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 2
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 2
- MWTGBAURSCEGSL-UHFFFAOYSA-N 3-(benzylamino)propanenitrile Chemical compound N#CCCNCC1=CC=CC=C1 MWTGBAURSCEGSL-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- STWODXDTKGTVCJ-UHFFFAOYSA-N 4-pyrrolidin-1-ylpiperidine Chemical compound C1CCCN1C1CCNCC1 STWODXDTKGTVCJ-UHFFFAOYSA-N 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 2
- OUXRMEUJNPVXMM-UHFFFAOYSA-N N,n-diethyl-4-piperidinamine Chemical compound CCN(CC)C1CCNCC1 OUXRMEUJNPVXMM-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229940122803 Vinca alkaloid Drugs 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- JPOXNPPZZKNXOV-UHFFFAOYSA-N bromochloromethane Chemical compound ClCBr JPOXNPPZZKNXOV-UHFFFAOYSA-N 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 230000001085 cytostatic effect Effects 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- XVIJMHJTEHBUJI-UHFFFAOYSA-N ethyl 3-(methylamino)propanoate Chemical compound CCOC(=O)CCNC XVIJMHJTEHBUJI-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- PEYVWSJAZONVQK-UHFFFAOYSA-N hydroperoxy(oxo)borane Chemical compound OOB=O PEYVWSJAZONVQK-UHFFFAOYSA-N 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- XHOADYKJSBCVBJ-UHFFFAOYSA-N n,n-diethylpyrrolidin-3-amine Chemical compound CCN(CC)C1CCNC1 XHOADYKJSBCVBJ-UHFFFAOYSA-N 0.000 description 2
- YFJAIURZMRJPDB-UHFFFAOYSA-N n,n-dimethylpiperidin-4-amine Chemical compound CN(C)C1CCNCC1 YFJAIURZMRJPDB-UHFFFAOYSA-N 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 150000007530 organic bases Chemical group 0.000 description 2
- SGGWHQYGJKHLGQ-UHFFFAOYSA-N oxalic acid;pyrimidine Chemical compound C1=CN=CN=C1.OC(=O)C(O)=O SGGWHQYGJKHLGQ-UHFFFAOYSA-N 0.000 description 2
- 150000004965 peroxy acids Chemical class 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000006268 reductive amination reaction Methods 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- XRNVSPDQTPVECU-UHFFFAOYSA-N (4-bromophenyl)methanamine Chemical compound NCC1=CC=C(Br)C=C1 XRNVSPDQTPVECU-UHFFFAOYSA-N 0.000 description 1
- YMVFJGSXZNNUDW-UHFFFAOYSA-N (4-chlorophenyl)methanamine Chemical compound NCC1=CC=C(Cl)C=C1 YMVFJGSXZNNUDW-UHFFFAOYSA-N 0.000 description 1
- IIFVWLUQBAIPMJ-UHFFFAOYSA-N (4-fluorophenyl)methanamine Chemical compound NCC1=CC=C(F)C=C1 IIFVWLUQBAIPMJ-UHFFFAOYSA-N 0.000 description 1
- HMTSWYPNXFHGEP-UHFFFAOYSA-N (4-methylphenyl)methanamine Chemical compound CC1=CC=C(CN)C=C1 HMTSWYPNXFHGEP-UHFFFAOYSA-N 0.000 description 1
- 125000004455 (C1-C3) alkylthio group Chemical group 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 description 1
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 description 1
- 125000006091 1,3-dioxolane group Chemical group 0.000 description 1
- KPKNTUUIEVXMOH-UHFFFAOYSA-N 1,4-dioxa-8-azaspiro[4.5]decane Chemical compound O1CCOC11CCNCC1 KPKNTUUIEVXMOH-UHFFFAOYSA-N 0.000 description 1
- CQFHBHZIZNVPLT-UHFFFAOYSA-N 1-(4,8-dimorpholin-4-ylpyrimido[5,4-d]pyrimidin-2-yl)-n,n-dimethylpiperidin-4-amine Chemical compound C1CC(N(C)C)CCN1C1=NC(N2CCOCC2)=C(N=CN=C2N3CCOCC3)C2=N1 CQFHBHZIZNVPLT-UHFFFAOYSA-N 0.000 description 1
- XKYKAQFAEQFYDF-UHFFFAOYSA-N 1-(4-methoxynaphthalen-1-yl)-n-methylmethanamine Chemical compound C1=CC=C2C(CNC)=CC=C(OC)C2=C1 XKYKAQFAEQFYDF-UHFFFAOYSA-N 0.000 description 1
- FNQVQHMCOZRJQT-UHFFFAOYSA-N 1-[8-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-2-yl]piperidin-4-amine Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1C(C1=N2)=NC=NC1=C(N1CCOCC1)N=C2N1CCC(N)CC1 FNQVQHMCOZRJQT-UHFFFAOYSA-N 0.000 description 1
- IWHLPMBLJZJCJK-UHFFFAOYSA-N 1-cyclohexyl-n-methylmethanamine Chemical compound CNCC1CCCCC1 IWHLPMBLJZJCJK-UHFFFAOYSA-N 0.000 description 1
- MKIMESGTNAZHPU-UHFFFAOYSA-N 1-phenyl-1,3,8-triazaspiro[4.5]decane Chemical compound C=1C=CC=CC=1N1CNCC21CCNCC2 MKIMESGTNAZHPU-UHFFFAOYSA-N 0.000 description 1
- CVXSNGXWRHLZFU-UHFFFAOYSA-N 2,8-dichloro-4-(3,4-dihydro-1h-isoquinolin-2-yl)pyrimido[5,4-d]pyrimidine Chemical compound N1=CN=C(Cl)C2=NC(Cl)=NC(N3CC4=CC=CC=C4CC3)=C21 CVXSNGXWRHLZFU-UHFFFAOYSA-N 0.000 description 1
- MAWKNUDUKRUYMB-UHFFFAOYSA-N 2,8-dichloro-4-piperidin-1-ylpyrimido[5,4-d]pyrimidine Chemical compound C=12N=CN=C(Cl)C2=NC(Cl)=NC=1N1CCCCC1 MAWKNUDUKRUYMB-UHFFFAOYSA-N 0.000 description 1
- UOPRPCBCBQMLEB-UHFFFAOYSA-N 2,8-dichloro-n,n-diethylpyrimido[5,4-d]pyrimidin-4-amine Chemical compound N1=CN=C2C(N(CC)CC)=NC(Cl)=NC2=C1Cl UOPRPCBCBQMLEB-UHFFFAOYSA-N 0.000 description 1
- ZESYFFOWIGNGIO-UHFFFAOYSA-N 2-(2-chloro-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-yl)-3,4-dihydro-1h-isoquinoline-6,7-diol Chemical compound C1C=2C=C(O)C(O)=CC=2CCN1C(C1=NC(Cl)=N2)=NC=NC1=C2N1CCOCC1 ZESYFFOWIGNGIO-UHFFFAOYSA-N 0.000 description 1
- KGSVNOLLROCJQM-UHFFFAOYSA-N 2-(benzylamino)acetic acid Chemical compound OC(=O)CNCC1=CC=CC=C1 KGSVNOLLROCJQM-UHFFFAOYSA-N 0.000 description 1
- BHUGZIJOVAVBOQ-UHFFFAOYSA-N 2-(propylazaniumyl)acetate Chemical compound CCCNCC(O)=O BHUGZIJOVAVBOQ-UHFFFAOYSA-N 0.000 description 1
- LSNYLERJYCQZJQ-UHFFFAOYSA-N 2-[4-(dimethylamino)piperidin-1-yl]-4-morpholin-4-yl-n-(2-phenylethyl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CC(N(C)C)CCN1C1=NC(N2CCOCC2)=C(N=CN=C2NCCC=3C=CC=CC=3)C2=N1 LSNYLERJYCQZJQ-UHFFFAOYSA-N 0.000 description 1
- WGHDZNWJFOKVAA-UHFFFAOYSA-N 2-[4-(dimethylamino)piperidin-1-yl]-4-morpholin-4-yl-n-(3-phenylpropyl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CC(N(C)C)CCN1C1=NC(N2CCOCC2)=C(N=CN=C2NCCCC=3C=CC=CC=3)C2=N1 WGHDZNWJFOKVAA-UHFFFAOYSA-N 0.000 description 1
- GGVKOUYATPPSAF-UHFFFAOYSA-N 2-[4-(dimethylamino)piperidin-1-yl]-n-[(4-methoxynaphthalen-1-yl)methyl]-n-methyl-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C12=CC=CC=C2C(OC)=CC=C1CN(C)C(C1=N2)=NC=NC1=C(N1CCOCC1)N=C2N1CCC(N(C)C)CC1 GGVKOUYATPPSAF-UHFFFAOYSA-N 0.000 description 1
- ZQSYDLQIVJCQGA-UHFFFAOYSA-N 2-[4-(dimethylamino)piperidin-1-yl]-n-[(4-methoxyphenyl)methyl]-n-methyl-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=CC(OC)=CC=C1CN(C)C1=NC=NC2=C(N3CCOCC3)N=C(N3CCC(CC3)N(C)C)N=C12 ZQSYDLQIVJCQGA-UHFFFAOYSA-N 0.000 description 1
- IYGVKKSDSOSZJV-UHFFFAOYSA-N 2-[4-(dimethylamino)piperidin-1-yl]-n-[(4-methylphenyl)methyl]-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CC(N(C)C)CCN1C1=NC(N2CCOCC2)=C(N=CN=C2NCC=3C=CC(C)=CC=3)C2=N1 IYGVKKSDSOSZJV-UHFFFAOYSA-N 0.000 description 1
- FKUZSBRIEKTUCC-UHFFFAOYSA-N 2-[benzyl-[2-[4-(dimethylamino)piperidin-1-yl]-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-yl]amino]acetic acid Chemical compound C1CC(N(C)C)CCN1C1=NC(N2CCOCC2)=C(N=CN=C2N(CC(O)=O)CC=3C=CC=CC=3)C2=N1 FKUZSBRIEKTUCC-UHFFFAOYSA-N 0.000 description 1
- SMBOFEIJKBINQD-UHFFFAOYSA-N 2-chloro-n-(cyclohexylmethyl)-n-methyl-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCOCC3)N=C(Cl)N=C2C=1N(C)CC1CCCCC1 SMBOFEIJKBINQD-UHFFFAOYSA-N 0.000 description 1
- OXBQYWGGRRCMIM-UHFFFAOYSA-N 2-chloro-n-[(4-chlorophenyl)methyl]-n-methyl-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCOCC3)N=C(Cl)N=C2C=1N(C)CC1=CC=C(Cl)C=C1 OXBQYWGGRRCMIM-UHFFFAOYSA-N 0.000 description 1
- GYCTVWOYMAHFBV-UHFFFAOYSA-N 2-chloro-n-[(4-methoxynaphthalen-1-yl)methyl]-n-methyl-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C12=CC=CC=C2C(OC)=CC=C1CN(C)C(C1=NC(Cl)=N2)=NC=NC1=C2N1CCOCC1 GYCTVWOYMAHFBV-UHFFFAOYSA-N 0.000 description 1
- GUUZIICWUODTQX-UHFFFAOYSA-N 2-chloro-n-[(4-methoxyphenyl)methyl]-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=CC(OC)=CC=C1CNC1=NC=NC2=C(N3CCOCC3)N=C(Cl)N=C12 GUUZIICWUODTQX-UHFFFAOYSA-N 0.000 description 1
- SHLGAHGBEJLXLO-UHFFFAOYSA-N 2-chloro-n-[(4-methoxyphenyl)methyl]-n-methyl-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=CC(OC)=CC=C1CN(C)C1=NC=NC2=C(N3CCOCC3)N=C(Cl)N=C12 SHLGAHGBEJLXLO-UHFFFAOYSA-N 0.000 description 1
- DPHFZHWBTMCYPO-UHFFFAOYSA-N 2-chloro-n-[(4-methylphenyl)methyl]-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=CC(C)=CC=C1CNC1=NC=NC2=C(N3CCOCC3)N=C(Cl)N=C12 DPHFZHWBTMCYPO-UHFFFAOYSA-N 0.000 description 1
- LVMWNRQZQGCHRD-UHFFFAOYSA-N 2-chloro-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)C1=NC=NC2=C(N3CCOCC3)N=C(Cl)N=C12 LVMWNRQZQGCHRD-UHFFFAOYSA-N 0.000 description 1
- YCGLOZYVBRBNKR-UHFFFAOYSA-N 2-chloro-n-methyl-4-morpholin-4-yl-n-(naphthalen-1-ylmethyl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)C(C1=NC(Cl)=N2)=NC=NC1=C2N1CCOCC1 YCGLOZYVBRBNKR-UHFFFAOYSA-N 0.000 description 1
- ZFBCUYHHCKDHMW-UHFFFAOYSA-N 2-chloro-n-methyl-4-morpholin-4-yl-n-(naphthalen-2-ylmethyl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=1C=C2C=CC=CC2=CC=1CN(C)C(C1=NC(Cl)=N2)=NC=NC1=C2N1CCOCC1 ZFBCUYHHCKDHMW-UHFFFAOYSA-N 0.000 description 1
- AVKQCAIJQBKBKC-UHFFFAOYSA-N 2-chloro-n-methyl-n-[(4-methylphenyl)methyl]-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCOCC3)N=C(Cl)N=C2C=1N(C)CC1=CC=C(C)C=C1 AVKQCAIJQBKBKC-UHFFFAOYSA-N 0.000 description 1
- 125000005975 2-phenylethyloxy group Chemical group 0.000 description 1
- NDMPLJNOPCLANR-UHFFFAOYSA-N 3,4-dihydroxy-15-(4-hydroxy-18-methoxycarbonyl-5,18-seco-ibogamin-18-yl)-16-methoxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 NDMPLJNOPCLANR-UHFFFAOYSA-N 0.000 description 1
- UNIJBMUBHBAUET-UHFFFAOYSA-N 3-(methylamino)propanenitrile Chemical compound CNCCC#N UNIJBMUBHBAUET-UHFFFAOYSA-N 0.000 description 1
- IRIOFUVLMGOLFE-UHFFFAOYSA-N 3-(propylamino)propanoic acid Chemical compound CCCNCCC(O)=O IRIOFUVLMGOLFE-UHFFFAOYSA-N 0.000 description 1
- STBDXSALGFNTHC-UHFFFAOYSA-N 3-[benzyl-(2-chloro-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-yl)amino]propanenitrile Chemical compound C=12N=CN=C(N(CCC#N)CC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCOCC1 STBDXSALGFNTHC-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- AGDHSWAZTKYTNX-UHFFFAOYSA-N 3-phenyl-n-propan-2-ylpropan-1-amine Chemical compound CC(C)NCCCC1=CC=CC=C1 AGDHSWAZTKYTNX-UHFFFAOYSA-N 0.000 description 1
- DYERXDHKGZKVGS-UHFFFAOYSA-N 3-phenyl-n-propylpropan-1-amine Chemical compound CCCNCCCC1=CC=CC=C1 DYERXDHKGZKVGS-UHFFFAOYSA-N 0.000 description 1
- LYUQWQRTDLVQGA-UHFFFAOYSA-N 3-phenylpropylamine Chemical compound NCCCC1=CC=CC=C1 LYUQWQRTDLVQGA-UHFFFAOYSA-N 0.000 description 1
- PRJTXJHOVIGWNZ-UHFFFAOYSA-N 4-(2,2-diphenylethyl)piperidine Chemical compound C1CNCCC1CC(C=1C=CC=CC=1)C1=CC=CC=C1 PRJTXJHOVIGWNZ-UHFFFAOYSA-N 0.000 description 1
- NWCMUXXOBVJKPH-UHFFFAOYSA-N 4-(2-chloro-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-yl)morpholine Chemical compound C=12N=CN=C(N3CCOCC3)C2=NC(Cl)=NC=1N1CCOCC1 NWCMUXXOBVJKPH-UHFFFAOYSA-N 0.000 description 1
- YZYXKCUCMUSEEV-UHFFFAOYSA-N 4-(2-chloro-8-phenylmethoxypyrimido[5,4-d]pyrimidin-4-yl)morpholine Chemical compound C=12N=CN=C(OCC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCOCC1 YZYXKCUCMUSEEV-UHFFFAOYSA-N 0.000 description 1
- HHQWKZLAQJGWCH-UHFFFAOYSA-N 4-(8-benzylsulfanyl-2-chloropyrimido[5,4-d]pyrimidin-4-yl)morpholine Chemical compound C=12N=CN=C(SCC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCOCC1 HHQWKZLAQJGWCH-UHFFFAOYSA-N 0.000 description 1
- NZJWITSLFKTATC-UHFFFAOYSA-N 4-(benzylamino)butanenitrile Chemical compound N#CCCCNCC1=CC=CC=C1 NZJWITSLFKTATC-UHFFFAOYSA-N 0.000 description 1
- XZJMQNMFQZJPHN-UHFFFAOYSA-N 4-(benzylazaniumyl)butanoate Chemical compound OC(=O)CCCNCC1=CC=CC=C1 XZJMQNMFQZJPHN-UHFFFAOYSA-N 0.000 description 1
- IMINWALBEYQLAW-UHFFFAOYSA-N 4-(ethylamino)butanenitrile Chemical compound CCNCCCC#N IMINWALBEYQLAW-UHFFFAOYSA-N 0.000 description 1
- FSCWTVQILXCITB-UHFFFAOYSA-N 4-(ethylazaniumyl)butanoate Chemical compound CCNCCCC(O)=O FSCWTVQILXCITB-UHFFFAOYSA-N 0.000 description 1
- HOPPOPHWXVRHLG-UHFFFAOYSA-N 4-(methylamino)butanenitrile Chemical compound CNCCCC#N HOPPOPHWXVRHLG-UHFFFAOYSA-N 0.000 description 1
- AMLYYOLAQDRQED-UHFFFAOYSA-N 4-(propylazaniumyl)butanoate Chemical compound CCCNCCCC(O)=O AMLYYOLAQDRQED-UHFFFAOYSA-N 0.000 description 1
- LGFWFHVAVVEHBR-UHFFFAOYSA-N 4-[2-chloro-8-(1,3-dihydroisoindol-2-yl)pyrimido[5,4-d]pyrimidin-4-yl]morpholine Chemical compound C=12N=CN=C(N3CC4=CC=CC=C4C3)C2=NC(Cl)=NC=1N1CCOCC1 LGFWFHVAVVEHBR-UHFFFAOYSA-N 0.000 description 1
- XGYKKVTZDQDYJQ-UHFFFAOYSA-N 4-aminobutanenitrile Chemical compound NCCCC#N XGYKKVTZDQDYJQ-UHFFFAOYSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
- LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 description 1
- VRJHQPZVIGNGMX-UHFFFAOYSA-N 4-piperidinone Chemical compound O=C1CCNCC1 VRJHQPZVIGNGMX-UHFFFAOYSA-N 0.000 description 1
- WXOCMZMQYVOHCM-UHFFFAOYSA-N 4-pyrimidin-4-ylmorpholine Chemical compound C1COCCN1C1=CC=NC=N1 WXOCMZMQYVOHCM-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- WMCHXIVYXRICAW-UHFFFAOYSA-N 8-n-benzyl-2-chloro-4-n,4-n-diethyl-8-n-methylpyrimido[5,4-d]pyrimidine-4,8-diamine Chemical compound N1=CN=C2C(N(CC)CC)=NC(Cl)=NC2=C1N(C)CC1=CC=CC=C1 WMCHXIVYXRICAW-UHFFFAOYSA-N 0.000 description 1
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical group NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- UWWNKCHZJSKOPC-UHFFFAOYSA-N C(C)(=O)NC1=C(C=CC=C1N)N Chemical compound C(C)(=O)NC1=C(C=CC=C1N)N UWWNKCHZJSKOPC-UHFFFAOYSA-N 0.000 description 1
- KZENVFXKZSKQSS-UHFFFAOYSA-N COC1=C(C=C2CN(CCC2=C1)C3=NC=NC4=C3N=CN=C4N5CCOCC5)OC Chemical compound COC1=C(C=C2CN(CCC2=C1)C3=NC=NC4=C3N=CN=C4N5CCOCC5)OC KZENVFXKZSKQSS-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- AFKJMYMNJWYPRI-UHFFFAOYSA-N N,N,4-trimethylnaphthalen-2-amine Chemical compound CN(C)c1cc(C)c2ccccc2c1 AFKJMYMNJWYPRI-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- VYGABLBXWJKMRI-UHFFFAOYSA-N N-[(4-fluoronaphthalen-1-yl)methyl]ethanamine Chemical compound C1=CC=C2C(CNCC)=CC=C(F)C2=C1 VYGABLBXWJKMRI-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- CKUAXEQHGKSLHN-UHFFFAOYSA-N [C].[N] Chemical compound [C].[N] CKUAXEQHGKSLHN-UHFFFAOYSA-N 0.000 description 1
- 229940022682 acetone Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001508 alkali metal halide Inorganic materials 0.000 description 1
- 150000008045 alkali metal halides Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- LHNICELDCMPPDE-UHFFFAOYSA-N anthracen-9-amine Chemical compound C1=CC=C2C(N)=C(C=CC=C3)C3=CC2=C1 LHNICELDCMPPDE-UHFFFAOYSA-N 0.000 description 1
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 1
- 239000003817 anthracycline antibiotic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- WJUBYASTGWKFHK-UHFFFAOYSA-N azepan-3-amine Chemical compound NC1CCCCNC1 WJUBYASTGWKFHK-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- AGSPXMVUFBBBMO-UHFFFAOYSA-N beta-aminopropionitrile Chemical compound NCCC#N AGSPXMVUFBBBMO-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GUGRBFQNXVKOGR-UHFFFAOYSA-N butyl hypochlorite Chemical group CCCCOCl GUGRBFQNXVKOGR-UHFFFAOYSA-N 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- ULOLIZHBYWAICY-UHFFFAOYSA-N ethyl 2-(benzylamino)acetate Chemical compound CCOC(=O)CNCC1=CC=CC=C1 ULOLIZHBYWAICY-UHFFFAOYSA-N 0.000 description 1
- NRMPJIHWGVBZBB-UHFFFAOYSA-N ethyl 2-(ethylamino)acetate Chemical compound CCNCC(=O)OCC NRMPJIHWGVBZBB-UHFFFAOYSA-N 0.000 description 1
- WKTWNXRXMYEOJM-UHFFFAOYSA-N ethyl 2-[benzyl-(2-chloro-4-piperidin-1-ylpyrimido[5,4-d]pyrimidin-8-yl)amino]acetate Chemical compound N=1C=NC2=C(N3CCCCC3)N=C(Cl)N=C2C=1N(CC(=O)OCC)CC1=CC=CC=C1 WKTWNXRXMYEOJM-UHFFFAOYSA-N 0.000 description 1
- HCTJHQFFNDLDPF-UHFFFAOYSA-N ethyl 3-(benzylamino)propanoate Chemical compound CCOC(=O)CCNCC1=CC=CC=C1 HCTJHQFFNDLDPF-UHFFFAOYSA-N 0.000 description 1
- CNRWEHBBGLCEHG-UHFFFAOYSA-N ethyl 3-(ethylamino)propanoate Chemical compound CCNCCC(=O)OCC CNRWEHBBGLCEHG-UHFFFAOYSA-N 0.000 description 1
- SPOUHRALSDBNCQ-UHFFFAOYSA-N ethyl 4-(benzylamino)butanoate Chemical compound CCOC(=O)CCCNCC1=CC=CC=C1 SPOUHRALSDBNCQ-UHFFFAOYSA-N 0.000 description 1
- SZZGAYYWSNYVQI-UHFFFAOYSA-N ethyl 4-(ethylamino)butanoate Chemical compound CCNCCCC(=O)OCC SZZGAYYWSNYVQI-UHFFFAOYSA-N 0.000 description 1
- XAABBBQBNHRYFN-UHFFFAOYSA-N ethyl 4-(methylamino)butanoate Chemical compound CCOC(=O)CCCNC XAABBBQBNHRYFN-UHFFFAOYSA-N 0.000 description 1
- UAJFFNZUIRIPIF-UHFFFAOYSA-N ethyl 4-(propylamino)butanoate Chemical compound CCCNCCCC(=O)OCC UAJFFNZUIRIPIF-UHFFFAOYSA-N 0.000 description 1
- MAFQLJCYFMKEJJ-UHFFFAOYSA-N ethyl 4-aminobutanoate Chemical compound CCOC(=O)CCCN MAFQLJCYFMKEJJ-UHFFFAOYSA-N 0.000 description 1
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- JIRHHWNUZXRDHN-UHFFFAOYSA-N ethyl n-piperidin-4-ylcarbamate Chemical compound CCOC(=O)NC1CCNCC1 JIRHHWNUZXRDHN-UHFFFAOYSA-N 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910001853 inorganic hydroxide Inorganic materials 0.000 description 1
- 230000007154 intracellular accumulation Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- NTYRMCHEUGKRGZ-UHFFFAOYSA-N methyl 2-(piperidin-4-ylamino)acetate Chemical compound COC(=O)CNC1CCNCC1 NTYRMCHEUGKRGZ-UHFFFAOYSA-N 0.000 description 1
- QBMDDFSROMFCGA-UHFFFAOYSA-N methyl 2-(propylamino)acetate Chemical compound CCCNCC(=O)OC QBMDDFSROMFCGA-UHFFFAOYSA-N 0.000 description 1
- SQVLOTZNAGLYNN-UHFFFAOYSA-N methyl 2-[[1-[8-[benzyl(methyl)amino]-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-2-yl]piperidin-4-yl]amino]acetate Chemical compound C1CC(NCC(=O)OC)CCN1C1=NC(N2CCOCC2)=C(N=CN=C2N(C)CC=3C=CC=CC=3)C2=N1 SQVLOTZNAGLYNN-UHFFFAOYSA-N 0.000 description 1
- MVZIUHUSHIYYGP-UHFFFAOYSA-N methyl 3-(benzylamino)propanoate Chemical compound COC(=O)CCNCC1=CC=CC=C1 MVZIUHUSHIYYGP-UHFFFAOYSA-N 0.000 description 1
- KDGSVMQRTUAIDO-UHFFFAOYSA-N methyl 3-(ethylamino)propanoate Chemical compound CCNCCC(=O)OC KDGSVMQRTUAIDO-UHFFFAOYSA-N 0.000 description 1
- CDMLINZNKOVCCN-UHFFFAOYSA-N methyl 3-(propan-2-ylamino)propanoate Chemical compound COC(=O)CCNC(C)C CDMLINZNKOVCCN-UHFFFAOYSA-N 0.000 description 1
- UZCXPYDBYUEZCV-UHFFFAOYSA-N methyl 3-aminopropanoate Chemical compound COC(=O)CCN UZCXPYDBYUEZCV-UHFFFAOYSA-N 0.000 description 1
- NCHRVWIOGHJADK-UHFFFAOYSA-N methyl 4-(methylamino)butanoate Chemical compound CNCCCC(=O)OC NCHRVWIOGHJADK-UHFFFAOYSA-N 0.000 description 1
- RSJKCQHGLDSNIT-UHFFFAOYSA-N methyl 4-(propan-2-ylamino)butanoate Chemical compound COC(=O)CCCNC(C)C RSJKCQHGLDSNIT-UHFFFAOYSA-N 0.000 description 1
- KVQGGLZHHFGHPU-UHFFFAOYSA-N methyl 4-aminobutanoate Chemical compound COC(=O)CCCN KVQGGLZHHFGHPU-UHFFFAOYSA-N 0.000 description 1
- SELYJABLPLKXOY-UHFFFAOYSA-N methyl n,n-dimethylcarbamate Chemical compound COC(=O)N(C)C SELYJABLPLKXOY-UHFFFAOYSA-N 0.000 description 1
- PXEXCTZPRFTKBZ-UHFFFAOYSA-N methyl n-benzyl-n-methylcarbamate Chemical compound COC(=O)N(C)CC1=CC=CC=C1 PXEXCTZPRFTKBZ-UHFFFAOYSA-N 0.000 description 1
- CBZBASXHQRREBQ-UHFFFAOYSA-N methyl n-piperidin-4-ylcarbamate Chemical compound COC(=O)NC1CCNCC1 CBZBASXHQRREBQ-UHFFFAOYSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940073584 methylene chloride Drugs 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 230000036457 multidrug resistance Effects 0.000 description 1
- CURJNMSGPBXOGK-UHFFFAOYSA-N n',n'-di(propan-2-yl)ethane-1,2-diamine Chemical compound CC(C)N(C(C)C)CCN CURJNMSGPBXOGK-UHFFFAOYSA-N 0.000 description 1
- WIJFXKFYVBYDTA-UHFFFAOYSA-N n',n'-diethyl-n-propylethane-1,2-diamine Chemical compound CCCNCCN(CC)CC WIJFXKFYVBYDTA-UHFFFAOYSA-N 0.000 description 1
- UDGSVBYJWHOHNN-UHFFFAOYSA-N n',n'-diethylethane-1,2-diamine Chemical compound CCN(CC)CCN UDGSVBYJWHOHNN-UHFFFAOYSA-N 0.000 description 1
- IWMRIYWWKUYLBC-UHFFFAOYSA-N n',n'-dimethyl-n-piperidin-4-ylpropane-1,3-diamine Chemical compound CN(C)CCCNC1CCNCC1 IWMRIYWWKUYLBC-UHFFFAOYSA-N 0.000 description 1
- QXPRMANJAMOFLQ-UHFFFAOYSA-N n',n'-dimethyl-n-propan-2-ylethane-1,2-diamine Chemical compound CC(C)NCCN(C)C QXPRMANJAMOFLQ-UHFFFAOYSA-N 0.000 description 1
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
- HUQLOABSMDKQBW-UHFFFAOYSA-N n'-benzyl-n-methylethane-1,2-diamine Chemical compound CNCCNCC1=CC=CC=C1 HUQLOABSMDKQBW-UHFFFAOYSA-N 0.000 description 1
- ACYBVNYNIZTUIL-UHFFFAOYSA-N n'-benzylethane-1,2-diamine Chemical compound NCCNCC1=CC=CC=C1 ACYBVNYNIZTUIL-UHFFFAOYSA-N 0.000 description 1
- MXJYVLYENVWKQX-UHFFFAOYSA-N n'-ethyl-n-methylethane-1,2-diamine Chemical compound CCNCCNC MXJYVLYENVWKQX-UHFFFAOYSA-N 0.000 description 1
- SCZVXVGZMZRGRU-UHFFFAOYSA-N n'-ethylethane-1,2-diamine Chemical compound CCNCCN SCZVXVGZMZRGRU-UHFFFAOYSA-N 0.000 description 1
- KFIGICHILYTCJF-UHFFFAOYSA-N n'-methylethane-1,2-diamine Chemical compound CNCCN KFIGICHILYTCJF-UHFFFAOYSA-N 0.000 description 1
- NEOGNNUOIRLJLX-UHFFFAOYSA-N n'-piperidin-4-ylpropane-1,3-diamine Chemical compound NCCCNC1CCNCC1 NEOGNNUOIRLJLX-UHFFFAOYSA-N 0.000 description 1
- PRFYZNJWWYCSJL-UHFFFAOYSA-N n,n',n'-tripropylethane-1,2-diamine Chemical compound CCCNCCN(CCC)CCC PRFYZNJWWYCSJL-UHFFFAOYSA-N 0.000 description 1
- RLZCPYFMKMASKL-UHFFFAOYSA-N n,n'-dimethyl-n'-piperidin-4-ylethane-1,2-diamine Chemical compound CNCCN(C)C1CCNCC1 RLZCPYFMKMASKL-UHFFFAOYSA-N 0.000 description 1
- MVOJNQIUKOCFRI-UHFFFAOYSA-N n,n-dibenzyl-2-chloro-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(N(CC=3C=CC=CC=3)CC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCOCC1 MVOJNQIUKOCFRI-UHFFFAOYSA-N 0.000 description 1
- OKPWTHZKBRALMY-UHFFFAOYSA-N n,n-diethylazepan-3-amine Chemical compound CCN(CC)C1CCCCNC1 OKPWTHZKBRALMY-UHFFFAOYSA-N 0.000 description 1
- DNUNNDNXLGZGDL-UHFFFAOYSA-N n,n-diethylazepan-4-amine Chemical compound CCN(CC)C1CCCNCC1 DNUNNDNXLGZGDL-UHFFFAOYSA-N 0.000 description 1
- CQHNHCPXWQZRNK-UHFFFAOYSA-N n,n-dimethyl-2-[methyl(piperidin-4-yl)amino]acetamide Chemical compound CN(C)C(=O)CN(C)C1CCNCC1 CQHNHCPXWQZRNK-UHFFFAOYSA-N 0.000 description 1
- RRKCNYMLYVVFAP-UHFFFAOYSA-N n,n-dimethylazepan-3-amine Chemical compound CN(C)C1CCCCNC1 RRKCNYMLYVVFAP-UHFFFAOYSA-N 0.000 description 1
- CPQNSCBDTYTUGF-UHFFFAOYSA-N n,n-dimethylazepan-4-amine Chemical compound CN(C)C1CCCNCC1 CPQNSCBDTYTUGF-UHFFFAOYSA-N 0.000 description 1
- AVAWMINJNRAQFS-UHFFFAOYSA-N n,n-dimethylpyrrolidin-3-amine Chemical compound CN(C)C1CCNC1 AVAWMINJNRAQFS-UHFFFAOYSA-N 0.000 description 1
- KOTXCAOSNRHIMI-UHFFFAOYSA-N n-(2-aminoethyl)-1-phenylmethanesulfonamide Chemical compound NCCNS(=O)(=O)CC1=CC=CC=C1 KOTXCAOSNRHIMI-UHFFFAOYSA-N 0.000 description 1
- DAKZISABEDGGSV-UHFFFAOYSA-N n-(2-aminoethyl)acetamide Chemical compound CC(=O)NCCN DAKZISABEDGGSV-UHFFFAOYSA-N 0.000 description 1
- SUYTZMWLZYCZEF-UHFFFAOYSA-N n-(2-aminoethyl)propanamide Chemical compound CCC(=O)NCCN SUYTZMWLZYCZEF-UHFFFAOYSA-N 0.000 description 1
- IIIRPZWDICEMGU-UHFFFAOYSA-N n-(2-phenylethyl)propan-1-amine Chemical compound CCCNCCC1=CC=CC=C1 IIIRPZWDICEMGU-UHFFFAOYSA-N 0.000 description 1
- HNPAEWJKFXEUDW-UHFFFAOYSA-N n-(2-phenylethyl)propan-2-amine Chemical compound CC(C)NCCC1=CC=CC=C1 HNPAEWJKFXEUDW-UHFFFAOYSA-N 0.000 description 1
- JFVQSRKXAAXZIK-UHFFFAOYSA-N n-(naphthalen-1-ylmethyl)ethanamine Chemical compound C1=CC=C2C(CNCC)=CC=CC2=C1 JFVQSRKXAAXZIK-UHFFFAOYSA-N 0.000 description 1
- LIMYPCKNYIHPHN-UHFFFAOYSA-N n-(naphthalen-1-ylmethyl)propan-2-amine Chemical compound C1=CC=C2C(CNC(C)C)=CC=CC2=C1 LIMYPCKNYIHPHN-UHFFFAOYSA-N 0.000 description 1
- KSGVRUGRMOXBBQ-UHFFFAOYSA-N n-(naphthalen-2-ylmethyl)ethanamine Chemical compound C1=CC=CC2=CC(CNCC)=CC=C21 KSGVRUGRMOXBBQ-UHFFFAOYSA-N 0.000 description 1
- RCWFTXDLECHWKC-UHFFFAOYSA-N n-(naphthalen-2-ylmethyl)propan-1-amine Chemical compound C1=CC=CC2=CC(CNCCC)=CC=C21 RCWFTXDLECHWKC-UHFFFAOYSA-N 0.000 description 1
- TWSYFYMXABOVNG-UHFFFAOYSA-N n-(naphthalen-2-ylmethyl)propan-2-amine Chemical compound C1=CC=CC2=CC(CNC(C)C)=CC=C21 TWSYFYMXABOVNG-UHFFFAOYSA-N 0.000 description 1
- RVGAYUIZZCACIV-UHFFFAOYSA-N n-[(4-bromophenyl)methyl]ethanamine Chemical compound CCNCC1=CC=C(Br)C=C1 RVGAYUIZZCACIV-UHFFFAOYSA-N 0.000 description 1
- DFQJMTRRBIJCLB-UHFFFAOYSA-N n-[(4-bromophenyl)methyl]propan-2-amine Chemical compound CC(C)NCC1=CC=C(Br)C=C1 DFQJMTRRBIJCLB-UHFFFAOYSA-N 0.000 description 1
- DWQGKMSNZGJKJS-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]ethanamine Chemical compound CCNCC1=CC=C(Cl)C=C1 DWQGKMSNZGJKJS-UHFFFAOYSA-N 0.000 description 1
- YAZQVBQICNBWOE-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]propan-2-amine Chemical compound CC(C)NCC1=CC=C(Cl)C=C1 YAZQVBQICNBWOE-UHFFFAOYSA-N 0.000 description 1
- CURFQQZYGVCIGJ-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]ethanamine Chemical compound CCNCC1=CC=C(F)C=C1 CURFQQZYGVCIGJ-UHFFFAOYSA-N 0.000 description 1
- QXJDUPVWQCCQKO-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]propan-1-amine Chemical compound CCCNCC1=CC=C(F)C=C1 QXJDUPVWQCCQKO-UHFFFAOYSA-N 0.000 description 1
- SYGACMXWLAQEPN-UHFFFAOYSA-N n-[(4-methoxyphenyl)methyl]ethanamine Chemical compound CCNCC1=CC=C(OC)C=C1 SYGACMXWLAQEPN-UHFFFAOYSA-N 0.000 description 1
- NCOFJPJEQIGDEV-UHFFFAOYSA-N n-[(4-methoxyphenyl)methyl]propan-1-amine Chemical compound CCCNCC1=CC=C(OC)C=C1 NCOFJPJEQIGDEV-UHFFFAOYSA-N 0.000 description 1
- RVROZYOHWNUUNB-UHFFFAOYSA-N n-[(4-methoxyphenyl)methyl]propan-2-amine Chemical compound COC1=CC=C(CNC(C)C)C=C1 RVROZYOHWNUUNB-UHFFFAOYSA-N 0.000 description 1
- RQMKHMUNQWEHDI-UHFFFAOYSA-N n-[(4-methylphenyl)methyl]ethanamine Chemical compound CCNCC1=CC=C(C)C=C1 RQMKHMUNQWEHDI-UHFFFAOYSA-N 0.000 description 1
- KEPDRVSVMRMGCR-UHFFFAOYSA-N n-[(4-methylphenyl)methyl]propan-1-amine Chemical compound CCCNCC1=CC=C(C)C=C1 KEPDRVSVMRMGCR-UHFFFAOYSA-N 0.000 description 1
- OOCHMURHBNXLEJ-UHFFFAOYSA-N n-[(4-methylphenyl)methyl]propan-2-amine Chemical compound CC(C)NCC1=CC=C(C)C=C1 OOCHMURHBNXLEJ-UHFFFAOYSA-N 0.000 description 1
- WEJQQLAAKOHJRQ-UHFFFAOYSA-N n-[2-(2-chloro-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-yl)-3,4-dihydro-1h-isoquinolin-5-yl]acetamide Chemical compound C1CC=2C(NC(=O)C)=CC=CC=2CN1C(C1=NC(Cl)=N2)=NC=NC1=C2N1CCOCC1 WEJQQLAAKOHJRQ-UHFFFAOYSA-N 0.000 description 1
- MBXRLNWPEMYVIV-UHFFFAOYSA-N n-[2-(benzylamino)ethyl]acetamide Chemical compound CC(=O)NCCNCC1=CC=CC=C1 MBXRLNWPEMYVIV-UHFFFAOYSA-N 0.000 description 1
- FVKXSZWQAKQVBI-UHFFFAOYSA-N n-[2-(benzylamino)ethyl]propanamide Chemical compound CCC(=O)NCCNCC1=CC=CC=C1 FVKXSZWQAKQVBI-UHFFFAOYSA-N 0.000 description 1
- VWDISFJSMDADJI-UHFFFAOYSA-N n-[3-[benzyl-[2-[4-(dimethylamino)piperidin-1-yl]-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-yl]amino]propyl]benzamide Chemical compound C1CC(N(C)C)CCN1C1=NC(N2CCOCC2)=C(N=CN=C2N(CCCNC(=O)C=3C=CC=CC=3)CC=3C=CC=CC=3)C2=N1 VWDISFJSMDADJI-UHFFFAOYSA-N 0.000 description 1
- OFEPYKKVPFBJPL-UHFFFAOYSA-N n-benzyl-2,4-dichloro-n-methyl-1h-pyrimido[5,4-d]pyrimidin-4-amine Chemical compound N1=C(Cl)NC2=CN=CN=C2C1(Cl)N(C)CC1=CC=CC=C1 OFEPYKKVPFBJPL-UHFFFAOYSA-N 0.000 description 1
- WCLULZMGEWWQNF-UHFFFAOYSA-N n-benzyl-2-[4-(2,2-diphenylethylamino)piperidin-1-yl]-n-methyl-8-morpholin-4-ylpyrimido[5,4-d]pyrimidin-4-amine Chemical compound N=1C(N2CCC(CC2)NCC(C=2C=CC=CC=2)C=2C=CC=CC=2)=NC2=C(N3CCOCC3)N=CN=C2C=1N(C)CC1=CC=CC=C1 WCLULZMGEWWQNF-UHFFFAOYSA-N 0.000 description 1
- KXCXDESVYWWYMK-UHFFFAOYSA-N n-benzyl-2-[4-(dimethylamino)piperidin-1-yl]-n-methyl-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CC(N(C)C)CCN1C1=NC(N2CCOCC2)=C(N=CN=C2N(C)CC=3C=CC=CC=3)C2=N1 KXCXDESVYWWYMK-UHFFFAOYSA-N 0.000 description 1
- PWCKZDNEYXQQGH-UHFFFAOYSA-N n-benzyl-2-[4-(dimethylamino)piperidin-1-yl]-n-methyl-4-piperidin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CC(N(C)C)CCN1C1=NC(N2CCCCC2)=C(N=CN=C2N(C)CC=3C=CC=CC=3)C2=N1 PWCKZDNEYXQQGH-UHFFFAOYSA-N 0.000 description 1
- XEQNUBSYVFXPJR-UHFFFAOYSA-N n-benzyl-2-[4-(dimethylamino)piperidin-1-yl]-n-methyl-8-morpholin-4-ylpyrimido[5,4-d]pyrimidin-4-amine Chemical compound C1CC(N(C)C)CCN1C1=NC(N(C)CC=2C=CC=CC=2)=C(N=CN=C2N3CCOCC3)C2=N1 XEQNUBSYVFXPJR-UHFFFAOYSA-N 0.000 description 1
- XYQALCZKBXGKAD-UHFFFAOYSA-N n-benzyl-2-chloro-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCOCC1 XYQALCZKBXGKAD-UHFFFAOYSA-N 0.000 description 1
- HDCUHXOEAPCBCD-UHFFFAOYSA-N n-benzyl-2-chloro-n-ethyl-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCOCC3)N=C(Cl)N=C2C=1N(CC)CC1=CC=CC=C1 HDCUHXOEAPCBCD-UHFFFAOYSA-N 0.000 description 1
- VFXMWBGLBNFTSY-UHFFFAOYSA-N n-benzyl-n',n'-diethylethane-1,2-diamine Chemical compound CCN(CC)CCNCC1=CC=CC=C1 VFXMWBGLBNFTSY-UHFFFAOYSA-N 0.000 description 1
- LLSJAFHDYCTFCM-UHFFFAOYSA-N n-benzyl-n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCNCC1=CC=CC=C1 LLSJAFHDYCTFCM-UHFFFAOYSA-N 0.000 description 1
- AYOMQFAVBBILEJ-UHFFFAOYSA-N n-benzyl-n-ethylpiperidin-4-amine Chemical compound C1CNCCC1N(CC)CC1=CC=CC=C1 AYOMQFAVBBILEJ-UHFFFAOYSA-N 0.000 description 1
- JQSWRIGANADNJD-UHFFFAOYSA-N n-benzyl-n-methylpiperidin-4-amine Chemical compound C1CNCCC1N(C)CC1=CC=CC=C1 JQSWRIGANADNJD-UHFFFAOYSA-N 0.000 description 1
- HXJQTEAZWLTMEZ-UHFFFAOYSA-N n-benzylanthracen-9-amine Chemical compound C=12C=CC=CC2=CC2=CC=CC=C2C=1NCC1=CC=CC=C1 HXJQTEAZWLTMEZ-UHFFFAOYSA-N 0.000 description 1
- HVAAHUDGWQAAOJ-UHFFFAOYSA-N n-benzylethanamine Chemical compound CCNCC1=CC=CC=C1 HVAAHUDGWQAAOJ-UHFFFAOYSA-N 0.000 description 1
- OUMBFMLKPJUWDQ-UHFFFAOYSA-N n-benzylpropan-1-amine Chemical compound CCCNCC1=CC=CC=C1 OUMBFMLKPJUWDQ-UHFFFAOYSA-N 0.000 description 1
- WOHOHPONCSKXSQ-UHFFFAOYSA-N n-ethyl-2-phenylethanamine Chemical compound CCNCCC1=CC=CC=C1 WOHOHPONCSKXSQ-UHFFFAOYSA-N 0.000 description 1
- LKGGWEZXOKZNML-UHFFFAOYSA-N n-ethyl-3-phenylpropan-1-amine Chemical compound CCNCCCC1=CC=CC=C1 LKGGWEZXOKZNML-UHFFFAOYSA-N 0.000 description 1
- WLNSKTSWPYTNLY-UHFFFAOYSA-N n-ethyl-n',n'-dimethylethane-1,2-diamine Chemical compound CCNCCN(C)C WLNSKTSWPYTNLY-UHFFFAOYSA-N 0.000 description 1
- JTRGJKPTAQTNAS-UHFFFAOYSA-N n-ethyl-n-methylpiperidin-4-amine Chemical compound CCN(C)C1CCNCC1 JTRGJKPTAQTNAS-UHFFFAOYSA-N 0.000 description 1
- SCMGRVLNBVSIHZ-UHFFFAOYSA-N n-ethyl-n-propan-2-ylpiperidin-4-amine Chemical compound CCN(C(C)C)C1CCNCC1 SCMGRVLNBVSIHZ-UHFFFAOYSA-N 0.000 description 1
- VARJMVYCDHQKCG-UHFFFAOYSA-N n-ethylpiperidin-4-amine Chemical compound CCNC1CCNCC1 VARJMVYCDHQKCG-UHFFFAOYSA-N 0.000 description 1
- MQRIUFVBEVFILS-UHFFFAOYSA-N n-methyl-1-naphthalen-1-ylmethanamine Chemical compound C1=CC=C2C(CNC)=CC=CC2=C1 MQRIUFVBEVFILS-UHFFFAOYSA-N 0.000 description 1
- MLHBZVFOTDJTPK-UHFFFAOYSA-N n-methyl-3-phenylpropan-1-amine Chemical compound CNCCCC1=CC=CC=C1 MLHBZVFOTDJTPK-UHFFFAOYSA-N 0.000 description 1
- XQMQIMWCQMZJMX-UHFFFAOYSA-N n-methylanthracen-9-amine Chemical compound C1=CC=C2C(NC)=C(C=CC=C3)C3=CC2=C1 XQMQIMWCQMZJMX-UHFFFAOYSA-N 0.000 description 1
- SASNBVQSOZSTPD-UHFFFAOYSA-N n-methylphenethylamine Chemical compound CNCCC1=CC=CC=C1 SASNBVQSOZSTPD-UHFFFAOYSA-N 0.000 description 1
- FHTGZDVYPCEHFQ-UHFFFAOYSA-N n-methylpiperidin-4-amine Chemical compound CNC1CCNCC1 FHTGZDVYPCEHFQ-UHFFFAOYSA-N 0.000 description 1
- NGZYRKGJWYJGRS-UHFFFAOYSA-N n-methylpyrrolidin-3-amine Chemical compound CNC1CCNC1 NGZYRKGJWYJGRS-UHFFFAOYSA-N 0.000 description 1
- YUSMWODGNWPEBC-UHFFFAOYSA-N n-morpholin-4-ylacetamide Chemical compound CC(=O)NN1CCOCC1 YUSMWODGNWPEBC-UHFFFAOYSA-N 0.000 description 1
- 125000004888 n-propyl amino group Chemical group [H]N(*)C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- PEUGKEHLRUVPAN-UHFFFAOYSA-N piperidin-3-amine Chemical compound NC1CCCNC1 PEUGKEHLRUVPAN-UHFFFAOYSA-N 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- PKZWNUWLTUTFNG-UHFFFAOYSA-N propan-2-yl 2-(benzylamino)acetate Chemical compound CC(C)OC(=O)CNCC1=CC=CC=C1 PKZWNUWLTUTFNG-UHFFFAOYSA-N 0.000 description 1
- KRIIUKMNPFFPKX-UHFFFAOYSA-N propan-2-yl 2-(ethylamino)acetate Chemical compound CCNCC(=O)OC(C)C KRIIUKMNPFFPKX-UHFFFAOYSA-N 0.000 description 1
- WJFTXCSLMWOXBL-UHFFFAOYSA-N propan-2-yl 4-aminobutanoate Chemical compound CC(C)OC(=O)CCCN WJFTXCSLMWOXBL-UHFFFAOYSA-N 0.000 description 1
- ZLQUUMARLOVRLO-UHFFFAOYSA-N propan-2-yl n-methylcarbamate Chemical compound CNC(=O)OC(C)C ZLQUUMARLOVRLO-UHFFFAOYSA-N 0.000 description 1
- ZTZIOZSINIHHTP-UHFFFAOYSA-N propyl 3-(ethylamino)propanoate Chemical compound CCCOC(=O)CCNCC ZTZIOZSINIHHTP-UHFFFAOYSA-N 0.000 description 1
- SECVIKQTQMHGTN-UHFFFAOYSA-N propyl 3-(methylamino)propanoate Chemical compound CCCOC(=O)CCNC SECVIKQTQMHGTN-UHFFFAOYSA-N 0.000 description 1
- HNVOOAODSCLLHQ-UHFFFAOYSA-N propyl n-piperidin-4-ylcarbamate Chemical compound CCCOC(=O)NC1CCNCC1 HNVOOAODSCLLHQ-UHFFFAOYSA-N 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- NGXSWUFDCSEIOO-UHFFFAOYSA-N pyrrolidin-3-amine Chemical compound NC1CCNC1 NGXSWUFDCSEIOO-UHFFFAOYSA-N 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- UGGWPQSBPIFKDZ-KOTLKJBCSA-N vindesine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(N)=O)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 UGGWPQSBPIFKDZ-KOTLKJBCSA-N 0.000 description 1
- 229960004355 vindesine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4325900A DE4325900A1 (de) | 1993-08-02 | 1993-08-02 | Trisubstituierte Pyrimido [5,4-d] pyrimidine zur Modulation der Multidrugresistenz, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK91594A3 true SK91594A3 (en) | 1995-04-12 |
Family
ID=6494272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK915-94A SK91594A3 (en) | 1993-08-02 | 1994-07-29 | Trisubstituted pyrimido£5,4-d|-pyrimidines for modulation of multidrugs resistence, medicines containing these compouds and method of their preparation |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5618814A (ru) |
| EP (1) | EP0645390A1 (ru) |
| JP (1) | JPH0789963A (ru) |
| KR (1) | KR950005828A (ru) |
| CN (1) | CN1041091C (ru) |
| AU (1) | AU683888B2 (ru) |
| BG (1) | BG98931A (ru) |
| CA (1) | CA2129179A1 (ru) |
| CZ (1) | CZ184594A3 (ru) |
| DE (1) | DE4325900A1 (ru) |
| EE (1) | EE9400255A (ru) |
| FI (1) | FI943574A (ru) |
| HU (1) | HUT70957A (ru) |
| IL (1) | IL110509A (ru) |
| NO (1) | NO301479B1 (ru) |
| NZ (1) | NZ264133A (ru) |
| PL (1) | PL304512A1 (ru) |
| RO (1) | RO113557B1 (ru) |
| RU (1) | RU94028278A (ru) |
| SK (1) | SK91594A3 (ru) |
| TW (1) | TW251286B (ru) |
| ZA (1) | ZA945689B (ru) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW414798B (en) * | 1994-09-07 | 2000-12-11 | Thomae Gmbh Dr K | Pyrimido (5,4-d) pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| DE19608653A1 (de) * | 1996-03-06 | 1997-09-11 | Thomae Gmbh Dr K | Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| US6331543B1 (en) | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| US5958926A (en) | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| USRE37234E1 (en) * | 1996-11-01 | 2001-06-19 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
| US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
| NZ544472A (en) * | 2003-07-03 | 2009-04-30 | Myriad Genetics Inc | Compounds and therapeutical use thereof |
| US8309562B2 (en) * | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| DE102004002557A1 (de) * | 2004-01-17 | 2005-08-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen |
| US8258145B2 (en) * | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| CA2592900A1 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
| CN115650827B (zh) * | 2022-10-27 | 2024-03-15 | 戊言医药科技（上海）有限公司 | 用于一类蒽环类毒素衍生物的制备方法、中间体化合物及合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3069211D1 (en) * | 1979-07-03 | 1984-10-25 | Thomae Gmbh Dr K | 2-(perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them |
| DE2931573A1 (de) * | 1979-08-03 | 1981-02-26 | Thomae Gmbh Dr K | Mittel zur bekaempfung des wachstums von krebszellen und dessen herstellung |
| DE3049207A1 (de) * | 1980-12-27 | 1982-07-29 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel |
| DE3423092A1 (de) * | 1984-06-22 | 1986-01-02 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue 8-alkylthio-2-piperazino-pyrimido(5,4-d) pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel |
| DE3833392A1 (de) * | 1988-10-01 | 1990-04-05 | Thomae Gmbh Dr K | Verwendung von pyrimido(5,4-d)pyrimidinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel |
-
1993
- 1993-08-02 DE DE4325900A patent/DE4325900A1/de not_active Withdrawn
-
1994
- 1994-07-07 TW TW083106205A patent/TW251286B/zh active
- 1994-07-26 EP EP94111739A patent/EP0645390A1/de not_active Withdrawn
- 1994-07-27 RO RO94-01270A patent/RO113557B1/ro unknown
- 1994-07-28 BG BG98931A patent/BG98931A/bg unknown
- 1994-07-29 NZ NZ264133A patent/NZ264133A/en unknown
- 1994-07-29 CA CA002129179A patent/CA2129179A1/en not_active Abandoned
- 1994-07-29 SK SK915-94A patent/SK91594A3/sk unknown
- 1994-07-29 IL IL110509A patent/IL110509A/en not_active IP Right Cessation
- 1994-08-01 FI FI943574A patent/FI943574A/fi unknown
- 1994-08-01 ZA ZA945689A patent/ZA945689B/xx unknown
- 1994-08-01 JP JP6179359A patent/JPH0789963A/ja active Pending
- 1994-08-01 KR KR1019940018961A patent/KR950005828A/ko not_active Application Discontinuation
- 1994-08-01 CN CN94114910A patent/CN1041091C/zh not_active Expired - Fee Related
- 1994-08-01 RU RU94028278/04A patent/RU94028278A/ru unknown
- 1994-08-01 AU AU68813/94A patent/AU683888B2/en not_active Ceased
- 1994-08-01 NO NO942853A patent/NO301479B1/no unknown
- 1994-08-01 PL PL94304512A patent/PL304512A1/xx unknown
- 1994-08-01 HU HU9402253A patent/HUT70957A/hu unknown
- 1994-08-02 US US08/284,325 patent/US5618814A/en not_active Expired - Fee Related
- 1994-08-02 CZ CZ941845A patent/CZ184594A3/cs unknown
- 1994-11-23 EE EE9400255A patent/EE9400255A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9402253D0 (en) | 1994-09-28 |
| FI943574A (fi) | 1995-02-03 |
| BG98931A (en) | 1995-09-29 |
| NO942853D0 (ru) | 1994-08-01 |
| FI943574A0 (fi) | 1994-08-01 |
| KR950005828A (ko) | 1995-03-20 |
| AU6881394A (en) | 1995-02-09 |
| EP0645390A1 (de) | 1995-03-29 |
| EE9400255A (et) | 1996-02-15 |
| TW251286B (ru) | 1995-07-11 |
| CA2129179A1 (en) | 1995-02-03 |
| NZ264133A (en) | 1996-05-28 |
| AU683888B2 (en) | 1997-11-27 |
| US5618814A (en) | 1997-04-08 |
| CN1041091C (zh) | 1998-12-09 |
| ZA945689B (en) | 1996-02-01 |
| IL110509A (en) | 1998-01-04 |
| RO113557B1 (ro) | 1998-08-28 |
| CZ184594A3 (en) | 1995-02-15 |
| DE4325900A1 (de) | 1995-02-09 |
| HUT70957A (en) | 1995-11-28 |
| JPH0789963A (ja) | 1995-04-04 |
| NO301479B1 (no) | 1997-11-03 |
| CN1106405A (zh) | 1995-08-09 |
| NO942853L (no) | 1995-02-03 |
| RU94028278A (ru) | 1996-08-27 |
| IL110509A0 (en) | 1994-10-21 |
| PL304512A1 (en) | 1995-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4643141B2 (ja) | 肥満治療用のｍｃｈアンタゴニスト | |
| SK91594A3 (en) | Trisubstituted pyrimido£5,4-d|-pyrimidines for modulation of multidrugs resistence, medicines containing these compouds and method of their preparation | |
| AU2005303893A1 (en) | Pyrimidine compounds as histamine modulators | |
| EP1743886A1 (en) | Method of inhibiting neurotrophin-receptor binding | |
| CA2243994A1 (en) | 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production | |
| KR19990087551A (ko) | 피리미도[5,4-d]피리미딘, 이를 함유하는 약물, 이의 용도 및이의 제조방법 | |
| KR20020089372A (ko) | 알파-2 길항제로서의 퀴놀린 유도체 | |
| PL119520B1 (en) | Process for preparing novel,condensed pyrimidine derivatives pirimidina | |
| CA3225872A1 (en) | Azetidinyl pyrimidines and uses thereof | |
| KR20200022759A (ko) | 신규한 벤조파이란 유도체 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 함유하는 약학적 조성물 | |
| DE69302829T2 (de) | Bicyclische pyrimidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate | |
| DE69119323T2 (de) | Fluoräthylcamptothecinderivate | |
| CA1321996C (en) | Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds | |
| CN105061432B (zh) | 6H‑吲哚[2,3‑b]喹喔啉衍生物、药物组合物及其制备和应用 | |
| AU612470B2 (en) | Novel benzimidazol(1,2-c)quinazolines, their preparation and their use | |
| EP1846401B1 (en) | New 4-aminoquinoline derivatives as antimalarials | |
| CA1256432A (en) | 12-aminopyridazinopyrroloisoquinoline compounds | |
| EP1776982A1 (en) | Pyrimidine compounds as histamine modulators | |
| EP3098222B1 (en) | Fused acridine derivative and pharmaceutical composition, preparation method and use thereof | |
| US20010046991A1 (en) | Derivatives of quinoline as alpha-2 antagonists | |
| HU203347B (en) | Process for producing new condensed diazepines and pharmaceutical compositions comprising same | |
| KR100853106B1 (ko) | 6,9-이치환된 2-(트랜스-1,4-디아미노사이클로헥실)-퓨린의 아실 및 설포닐 유도체 및 항증식제로서의 이들의 용도 | |
| US3914423A (en) | Quinazoline and isoquinoline bronchodilators | |
| El-Deen et al. | Research Journal of Pharmaceutical, Biological and Chemical Sciences | |
| DE19502179A1 (de) | Trisubstituierte Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |